$HARP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Harpoon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Harpoon Therapeutics, Inc.. Get notifications about new insider transactions in Harpoon Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.00 | 570 | 6,840 | 45,754 | 46.3 K to 45.8 K (-1.23 %) |
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 570 | 1,208 | 46,324 | 45.8 K to 46.3 K (+1.25 %) |
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.00 | 700 | 8,401 | 45,754 | 46.5 K to 45.8 K (-1.51 %) |
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 700 | 1,484 | 46,454 | 45.8 K to 46.5 K (+1.53 %) |
Apr 01 2020 | HARP | Harpoon Therapeuti ... | BAILES JOSEPH S | Director | Option Exercise | A | 11.78 | 20,335 | 239,546 | 20,335 | |
Apr 01 2020 | HARP | Harpoon Therapeuti ... | Robbins Andrew R | Director | Option Exercise | A | 11.78 | 20,335 | 239,546 | 20,335 | |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,520 | 3,222 | 48,668 | |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1 | 2 | 50,188 | |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.00 | 1,520 | 18,240 | 45,754 | 47.3 K to 45.8 K (-3.22 %) |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,520 | 3,222 | 47,274 | 45.8 K to 47.3 K (+3.32 %) |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.00 | 1 | 12 | 45,754 | 45.8 K to 45.8 K (0.00 %) |
Mar 18 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1 | 2 | 45,755 | 45.8 K to 45.8 K (0.00 %) |
Mar 03 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 5,826 | 12,351 | 180,578 | |
Mar 03 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 14.68 | 5,826 | 85,526 | 45,754 | 51.6 K to 45.8 K (-11.30 %) |
Mar 03 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 5,826 | 12,351 | 51,580 | 45.8 K to 51.6 K (+12.73 %) |
Feb 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,521 | 3,225 | 50,189 | |
Feb 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 15.00 | 1,521 | 22,815 | 45,754 | 47.3 K to 45.8 K (-3.22 %) |
Feb 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,521 | 3,225 | 47,275 | 45.8 K to 47.3 K (+3.32 %) |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | A | 13.29 | 52,313 | 695,240 | 52,313 | |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 5,826 | 12,351 | 186,404 | |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | A | 13.29 | 75,440 | 1,002,598 | 75,440 | |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 13.90 | 5,826 | 81,006 | 45,754 | 51.6 K to 45.8 K (-11.30 %) |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 5,826 | 12,351 | 51,580 | 45.8 K to 51.6 K (+12.73 %) |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Option Exercise | A | 13.29 | 52,160 | 693,206 | 52,160 | |
Feb 04 2020 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | A | 13.29 | 165,210 | 2,195,641 | 165,210 | |
Jan 23 2020 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | P | 14.09 | 6,700 | 94,418 | 6,700 | 0 to 6.7 K |
Jan 21 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,521 | 3,225 | 51,710 | |
Jan 21 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 14.94 | 1,521 | 22,725 | 45,754 | 47.3 K to 45.8 K (-3.22 %) |
Jan 21 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,521 | 3,225 | 47,275 | 45.8 K to 47.3 K (+3.32 %) |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 10,000 | 6,000 | 51,006 | |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.40 | 10,000 | 143,987 | 52,669 | 62.7 K to 52.7 K (-15.96 %) |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 10,000 | 6,000 | 62,669 | 52.7 K to 62.7 K (+18.99 %) |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 5,826 | 12,351 | 192,230 | |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 14.18 | 5,826 | 82,600 | 45,754 | 51.6 K to 45.8 K (-11.30 %) |
Jan 06 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 5,826 | 12,351 | 51,580 | 45.8 K to 51.6 K (+12.73 %) |
Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 18.07 | 1,400 | 25,297 | 262,136 | 263.5 K to 262.1 K (-0.53 %) |
Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 16.90 | 10,417 | 176,062 | 263,536 | 274 K to 263.5 K (-3.80 %) |
Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 15.81 | 75,562 | 1,194,922 | 273,953 | 349.5 K to 274 K (-21.62 %) |
Dec 18 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,521 | 3,225 | 53,231 | |
Dec 18 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 17.02 | 1,521 | 25,888 | 45,754 | 47.3 K to 45.8 K (-3.22 %) |
Dec 18 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,521 | 3,225 | 47,275 | 45.8 K to 47.3 K (+3.32 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 16.83 | 12,476 | 209,969 | 2,572,359 | 2.6 M to 2.6 M (-0.48 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 17.02 | 13,080 | 222,680 | 2,584,835 | 2.6 M to 2.6 M (-0.50 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 17.21 | 11,002 | 189,341 | 2,597,915 | 2.6 M to 2.6 M (-0.42 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 16.83 | 12,476 | 209,969 | 2,572,359 | 2.6 M to 2.6 M (-0.48 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 17.02 | 13,080 | 222,680 | 2,584,835 | 2.6 M to 2.6 M (-0.50 %) |
Dec 17 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 17.21 | 11,002 | 189,341 | 2,597,915 | 2.6 M to 2.6 M (-0.42 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 16.91 | 131,696 | 2,227,019 | 2,608,917 | 2.7 M to 2.6 M (-4.81 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 18.12 | 77,316 | 1,400,664 | 2,740,613 | 2.8 M to 2.7 M (-2.74 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 18.30 | 26,438 | 483,781 | 2,817,929 | 2.8 M to 2.8 M (-0.93 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 19.15 | 47,752 | 914,222 | 2,844,367 | 2.9 M to 2.8 M (-1.65 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 16.91 | 131,696 | 2,227,019 | 2,608,917 | 2.7 M to 2.6 M (-4.81 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 16.91 | 131,696 | 2,227,019 | 2,608,917 | 2.7 M to 2.6 M (-4.81 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 18.12 | 77,316 | 1,400,664 | 2,740,613 | 2.8 M to 2.7 M (-2.74 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 18.12 | 77,316 | 1,400,664 | 2,740,613 | 2.8 M to 2.7 M (-2.74 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 18.30 | 26,438 | 483,781 | 2,817,929 | 2.8 M to 2.8 M (-0.93 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 18.30 | 26,438 | 483,781 | 2,817,929 | 2.8 M to 2.8 M (-0.93 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 19.15 | 47,752 | 914,222 | 2,844,367 | 2.9 M to 2.8 M (-1.65 %) |
Dec 10 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Sell | S | 19.15 | 47,752 | 914,222 | 2,844,367 | 2.9 M to 2.8 M (-1.65 %) |
Dec 06 2019 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Option Exercise | M | 2.12 | 47,292 | 100,259 | 170,908 | |
Dec 06 2019 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | M | 2.12 | 47,292 | 100,259 | 47,292 | 0 to 47.3 K |
Dec 06 2019 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Option Exercise | M | 2.12 | 47,292 | 100,259 | 170,908 | |
Dec 06 2019 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | M | 2.12 | 47,292 | 100,259 | 47,292 | 0 to 47.3 K |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 5,826 | 12,351 | 198,056 | |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 17.98 | 5,826 | 104,751 | 45,754 | 51.6 K to 45.8 K (-11.30 %) |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 5,826 | 12,351 | 51,580 | 45.8 K to 51.6 K (+12.73 %) |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 5,826 | 12,351 | 198,056 | |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 17.98 | 5,826 | 104,751 | 45,754 | 51.6 K to 45.8 K (-11.30 %) |
Dec 04 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 5,826 | 12,351 | 51,580 | 45.8 K to 51.6 K (+12.73 %) |
Nov 19 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 18,252 | 38,694 | 54,752 | |
Nov 19 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 14.00 | 1,000 | 14,000 | 45,754 | 46.8 K to 45.8 K (-2.14 %) |
Nov 19 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 13.33 | 17,252 | 229,964 | 46,754 | 64 K to 46.8 K (-26.95 %) |
Nov 19 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 18,252 | 38,694 | 64,006 | 45.8 K to 64 K (+39.89 %) |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 11,698 | 24,800 | 209,708 | |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 12,452 | 26,398 | 221,406 | |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 13.21 | 11,698 | 154,481 | 45,754 | 57.5 K to 45.8 K (-20.36 %) |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 11,698 | 24,800 | 57,452 | 45.8 K to 57.5 K (+25.57 %) |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 13.27 | 12,452 | 165,280 | 45,754 | 58.2 K to 45.8 K (-21.39 %) |
Oct 16 2019 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 12,452 | 26,398 | 58,206 | 45.8 K to 58.2 K (+27.22 %) |
Sep 06 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | M | 0.60 | 169,462 | 101,677 | 318,590 | |
Sep 06 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | M | 0.60 | 169,462 | 101,677 | 172,462 | 3 K to 172.5 K (+5,648.73 %) |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | HUNT RONALD | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | EASTLAND JULIA MARIE | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
Jun 05 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
May 16 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.16 | 1,000 | 10,157 | 3,000 | 2 K to 3 K (+50.00 %) |
May 10 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.56 | 1,000 | 10,559 | 2,000 | 1,000 to 2 K (+100.00 %) |
May 07 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.53 | 1,000 | 10,530 | 1,000 | 0 to 1,000 |
Mar 29 2019 | HARP | Harpoon Therapeuti ... | EASTLAND JULIA MARIE | Director | Option Exercise | A | 14.00 | 5,907 | 82,698 | 5,907 | |
Mar 29 2019 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 14.00 | 4,266 | 59,724 | 4,266 | |
Mar 29 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 14.00 | 3,829 | 53,606 | 3,829 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Option Exercise | C | 0.00 | 742,850 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Option Exercise | C | 0.00 | 1,720,698 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Buy | P | 14.00 | 428,571 | 5,999,994 | 2,892,119 | 2.5 M to 2.9 M (+17.40 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Buy | C | 0.00 | 2,463,548 | 0 | 2,463,548 | 0 to 2.5 M |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | X | 0.05 | 50,838 | 2,501 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | X | 0.05 | 76,258 | 3,752 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 417,853 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,578,755 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,525,165 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | P | 14.00 | 250,000 | 3,500,000 | 3,898,422 | 3.6 M to 3.9 M (+6.85 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Sell | S | 14.00 | 447 | 6,258 | 3,648,422 | 3.6 M to 3.6 M (-0.01 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | X | 0.05 | 127,096 | 6,253 | 3,648,869 | 3.5 M to 3.6 M (+3.61 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 417,853 | 0 | 3,521,773 | 3.1 M to 3.5 M (+13.46 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 1,578,755 | 0 | 3,103,920 | 1.5 M to 3.1 M (+103.51 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | UBS Oncology Impact Fund L.P. | 10% Owner | Buy | C | 0.00 | 1,525,165 | 0 | 1,525,165 | 0 to 1.5 M |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 464,281 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 464,281 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,564,272 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Buy | P | 14.00 | 214,285 | 2,999,990 | 678,566 | 464.3 K to 678.6 K (+46.15 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Buy | P | 14.00 | 214,286 | 3,000,004 | 2,242,839 | 2 M to 2.2 M (+10.56 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 464,281 | 0 | 464,281 | 0 to 464.3 K |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 464,281 | 0 | 2,028,553 | 1.6 M to 2 M (+29.68 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | New Leaf Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 1,564,272 | 0 | 1,564,272 | 0 to 1.6 M |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 50,837 | 2,501 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 76,256 | 3,752 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 50,837 | 2,501 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 171,579 | 8,442 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 57,192 | 2,814 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | X | 0.05 | 25,418 | 1,251 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | C | 0.00 | 417,852 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,578,751 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,525,164 | 0 | 0 | |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | P | 14.00 | 250,000 | 3,500,000 | 4,524,425 | 4.3 M to 4.5 M (+5.85 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 14.00 | 1,524 | 21,336 | 4,274,425 | 4.3 M to 4.3 M (-0.04 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | X | 0.05 | 432,119 | 21,260 | 4,275,949 | 3.8 M to 4.3 M (+11.24 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | C | 0.00 | 417,852 | 0 | 3,843,830 | 3.4 M to 3.8 M (+12.20 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | C | 0.00 | 1,578,751 | 0 | 3,425,978 | 1.8 M to 3.4 M (+85.47 %) |
Feb 14 2019 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | C | 0.00 | 1,525,164 | 0 | 1,847,227 | 322.1 K to 1.8 M (+473.56 %) |